Early Detection Research Network

Chia, David

Contact Information

Email: mailto:dchia@ucla.edu
Fax: (310) 206-3216
Associate Member
1000
None given

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Breast tissue array 0 0
Early Detection of Urinary Bladder Cancer 0 0
The Early Detection Research Network: Biomarker Reference Laboratories 0 0
Validation of Biomarkers for the Early Detection of Colorectal Adenocarcinoma (GLNE 010) 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
GLNE 003: Preliminary Validation of Biomarkers Predictive of Barrett’s Esophagus Progression to Dysplasia and Adenocarcinoma 0 0
Lung Reference Set A Application: Lee Goodglick/ Eleftherios Diamandis- UCLA/MSH (2009) 0 0
Soluble Mesothelin Related Peptide (SMRP) and Osteopontin (OPN) as Early Detection Markers for Malignant Mesothelioma (MM) 2 0
Validation of Serum Markers for the Early Detection of Hepatocellular Carcinoma 3 0

Publications

Publication Name PubMed ID Journal
A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. 21504557 J Transl Med
Aromatase expression predicts survival in women with early-stage non small cell lung cancer. 17974992 Cancer Res.
COX-2-dependent stabilization of survivin in non-small cell lung cancer. 14597555 FASEB J.
Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. 16949910 Hum. Pathol.
Direct electronic detection of prostate-specific antigen in serum. 17352433 Small
Elevated MED28 expression predicts poor outcome in women with breast cancer. 20584319 BMC Cancer
Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. 21511357 Lung Cancer
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. 21689459 BMC Cancer
Expression of transcription factor Yin Yang 1 in prostate cancer. 15942652 Int. J. Oncol.
Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. 17947468 Clin. Cancer Res.
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. 23050525 N. Engl. J. Med.
Global levels of histone modifications predict prognosis in different cancers. 19349354 Am. J. Pathol.
Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome. 19729831 Cancer Biomark
Higher levels of GATA3 predict better survival in women with breast cancer. 21078439 Hum. Pathol.
Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. 15567174 Biochem. Biophys. Res. Commun.
Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. 22345575 Am. J. Physiol. Lung Cell Mol. Physiol.
Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer. 20710044 Cancer Res.
Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. 21600232 Steroids
Prostate cancer cell phenotypes based on AGR2 and CD10 expression. 23348903 Mod. Pathol.
Protein expression based multimarker analysis of breast cancer samples. 21651811 BMC Cancer
Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. 19887480 Clin. Cancer Res.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.